Riazi-Esfahani, M., Ahmadieh, H., Faghihi, H., Piri, N., Taei, R., Karkhaneh, R., . . . Sanagou, M. (2008). Intravitreal Bevacizumab versus Combined Bevacizumab and Triamcinolone Acetonide for Neovascular Age-Related Macular Degeneration. Ophthalmic Research Center.
استشهاد بنمط شيكاغوRiazi-Esfahani, Mohammad, et al. Intravitreal Bevacizumab Versus Combined Bevacizumab and Triamcinolone Acetonide for Neovascular Age-Related Macular Degeneration. Ophthalmic Research Center, 2008.
MLA استشهادRiazi-Esfahani, Mohammad, et al. Intravitreal Bevacizumab Versus Combined Bevacizumab and Triamcinolone Acetonide for Neovascular Age-Related Macular Degeneration. Ophthalmic Research Center, 2008.
تحذير: قد لا تكون هذه الاستشهادات دائما دقيقة بنسبة 100%.